Effect of Yangxinshi Tablets on the Phenotype and Function of Monocytes in Patients with Unstable Angina Pectoris of Coronary Heart Disease
  
View Full Text  View/Add Comment  Download reader
DOI:10.4103/wjtcm.wjtcm_39_19
KeyWord:Coronary heart disease, inflammatory factor, monocyte phenotype, unstable angina, Yangxinshi tablets
                 
AuthorInstitution
Li-Na Yangab a.Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University;b.Graduate School, Dalian Medical University, Dalian , China
Ming-Yu Wangab a.Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University;b.Graduate School, Dalian Medical University, Dalian , China
Ya-Qi Tongab a.Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University;b.Graduate School, Dalian Medical University, Dalian , China
Shu-Nan Zhangab a.Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University;b.Graduate School, Dalian Medical University, Dalian , China
Wei-Xia Wuab a.Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University;b.Graduate School, Dalian Medical University, Dalian , China
Yan-Chun Dinga a.Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University
Hits: 117
Download times: 201
Abstract:
      Objective: The objective of this study was to observe the effect of Yangxinshi tablets on the phenotype and function of peripheral blood monocytesin patients with unstable angina of coronary heart disease (CHD) and to explore the possible mechanism of Yangxinshi tabletsin the treatment of CHD. Methods: A total of 100 patients with unstable angina of CHD were randomly divided into two groups: GroupA– treatment group and Group B – control group. The phenotypic and functional changesin blood monocytes and the changesin serum inflammatory factors before and after treatment were compared in the two groups. Results: The expression of CD14+ CD163+ interleukin (IL)‑10+ was significantly higher in the control group than in the patients with unstable angina of CHD, whereas the expression of CD14+ CD163− IL‑12+ was lower. The concentration of IL‑10 was higher in the control group than in the patients with unstable angina, whereas the concentration of tumor necrosis factor-α (TNF‑α) and IL‑12 wassignificantly lower. In GroupA, the expression of CD14+ CD163+, CD14+ CD206+, and CD14+ CD163+ CD206+ in peripheral blood monocytes increased after treatment than before treatment, whereas the expression of CD14+ CD163− CD206− decreased. The expression of CD14+ CD163− IL‑12+ decreased after treatment than before, whereas CD14+ CD163+ IL‑10+ expression increased. The serum concentration of IL‑10 in Group A was higher after treatment than before, whereas that of IL‑12 and TNF‑α was lower. In Group B, the phenotype and function of the peripheral blood monocytes remained unchanged. Conclusion: Yangxinshi tablet therapy can change the phenotype of the peripheral blood monocytes in patients with unstable angina of CHD. Yangxinshi tablet therapy changes the inflammatory state in patients with an increase in the expression of anti‑inflammatory factors and a decrease in the expression of inflammatory factors.
Close